-
Current immunotherapies donβt work for most people with cancer. Researchers have identified an overlooked immune cell type that may react to targeted therapies to rally a more powerful immune response […]
Feb 27,2020
-
By Vanessa Steil – June 9,2020 In May, which happens to be Cancer Research Month, we co-hosted an Instagram Live with Stand Up To Cancer featuring our Chief Medical Advisor […]
Jun 09,2020
-
Nowadays ‘liquid biopsies,’ the notion of detecting cancer using only a blood test to detect minute amounts of circulating tumor are fairly well-known. But what if not even a blood […]
Jan 03,2019
-
The development of pancreatic cancer is driven by co-existing mutations in an oncogene involved in controlling cell growth, called KRAS, and in a tumor suppressor gene, called p53. But how […]
Jun 18,2020
-
Pancreatic cancer is a serious and often fatal disease, but a September study published inΒ Practical Radiation Oncology explores a new advancement in radiation therapy that may provide a better treatment […]
Oct 14,2020
-
A DNA mutation that occurs frequently in the development of many pancreatic tumors appears to make these cancers vulnerable to an existing type of drug known as PARP inhibitors, according […]
Dec 16,2020
-
The Lustgarten Foundation today announced the appointment of Linda Tantawi as Chief Executive Officer. As CEO, Tantawi will expand the organizationβs national presence to achieve its mission of finding a […]
Jan 29,2021
-
By Vanessa Steil When Joel Evans went to his endocrinologist in 2015 for what he thought would be a routine visit to monitor his diabetes, it turned into anything but. […]
Mar 08,2021